Global Business
Cultivating and Popularizing
SATO Brands through Six Global Branches
Focusing on the fast-growing ASEAN region, North America, and Europe,
Sato continues to develop its international business through its six branches in Taiwan, Hong Kong, Singapore, China, the US and Germany. We conduct marketing and sales activities carefully tailored to each business location, responding to regional and local needs.
International base and
international business partners
- ● International base
- ● Technology/product introduction
- ● Technology/product export
- ❶Pfizer Inc. (US)
- ❷The Procter & Gamble Company (US)
- ❸Foundation Consumer Brands (US)
- ❹Novan Inc. (US)
- ❺AstraZeneca plc (UK)
- ❻Glaxo Smith Kline (UK)
- ❼Sanofi (France)
- ❽IPSEN Consumer HealthCare SAS (France)
- ❾Laboratoires Dermatologiques D’Uriage (France)
- ❿Bayer AG (Germany)
- ⓫MEDA Pharma GmbH & Co. KG (Germany)
- ⓬Smart Practise Denmark ApS (Denmark)
- ⓭LEO Pharma A/S (Denmark)
- ❶CVS Pharmacy (US)
- ❷Walgreens (US)
- ❸London Drugs (Canada)
- ❹Church & Dwight (Australia) Pty Ltd. (Australia)
- ❺Eisai (Thailand) Marketing Co., Ltd. (Thailand)
- ❻DKSH (Malaysia)
- ❼Anugerah Pharmindo Lestari (Indonesia)
- ❽Baheal Pharmaceutical Group (China)
- ❾Zuellig Pharma (Vietnam, Philippines, Cambodia)
Marketing
Physical Advertising
Tailored to Regional Characteristics
In physical advertising, we have developed corporate ads at Yankee Stadium in the North America region, bus wrapping advertisements for the SATO brand in Singapore, and other ads tailored to each region.
Digital Advertising
That Communicates the Experiential Value of Products
We are currently enhancing our use of digital advertising, primarily in the ASEAN region. Digital advertising is centered on social networking ads that utilize popular bloggers and others to convey the value of the product experience.
Promoting the Global Expansion of Ethical Drugs
Sato Pharmaceutical is promoting the global expansion
of ethical drugs. Currently, we have obtained for approval for LUCONAC, our topical onychomycosis treatment, in Singapore, and plan to further expand the product in the US and ASEAN.